Methods for making proteins containing free cysteine residues
AssigneeBolder Biotechnology, Inc.
InventorsGeorge N. Cox, Daniel H. Doherty, Mary S. Rosendahl
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel methods of making soluble proteins having free cysteines in which a host cell is exposed to a cysteine blocking agent. The soluble proteins produced by the methods can then be modified to increase their effectiveness. Such modifications include attaching a PEG moiety to form pegylated proteins.
Claims21
-31. (canceled)
An isolated, disulfide-linked growth hormone protein dimer comprising two growth hormone protein monomers, wherein each growth hormone protein monomer in the dimer comprises at least one added cysteine residue, wherein at least one of the added cysteine residues participates in a disulfide bond joining the two growth hormone protein monomers together in the dimer, and wherein the protein dimer stimulates proliferation of a cell line that proliferates in response to growth hormone.
A method for obtaining an isolated, disulfide-linked growth hormone protein dimer comprising two growth hormone protein monomers, wherein each growth hormone protein monomer in the dimer comprises at least one added cysteine residue, and wherein the at least one added cysteine residue participates in a disulfide bond joining the two growth hormone protein monomers together in the dimer, the method comprising:
- (a) obtaining a host cell capable of expressing the growth hormone protein comprising at least one added cysteine residue;
- (b) causing the host cell to express the growth hormone protein comprising at least one added cysteine residue in a soluble form;
- (c) exposing the growth hormone protein comprising at least one added cysteine residue to a cysteine blocking agent prior to step (d);
- and
- (d) isolating the growth hormone protein dimer by column chromatography, wherein the buffers used to elute the growth hormone protein from the column do not contain a cysteine blocking agent.
A method of treating a disease treatable with growth hormone, comprising administering to a patient in need thereof an effective amount of a composition comprising an isolated, disulfide-linked growth hormone protein dimer comprising two growth hormone protein monomers, wherein each growth hormone protein monomer in the dimer comprises at least one added cysteine residue, and wherein the at least one added cysteine residue participates in a disulfide bond joining the two growth hormone protein monomers together in the dimer.
Dependencies are inferred from the claim text.